Bogdan Balas
56 works · 4,755 citations · h-index 20
Top works
- A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis
- Muscle and Liver Insulin Resistance Indexes Derived From the Oral Glucose Tolerance Test
- The Dipeptidyl Peptidase IV Inhibitor Vildagliptin Suppresses Endogenous Glucose Production and Enhances Islet Function after Single-Dose Administration in Type 2 Diabetic Patients
- Importance of Changes in Adipose Tissue Insulin Resistance to Histological Response During Thiazolidinedione Treatment of Patients with Nonalcoholic Steatohepatitis†
- Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study
- Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study
- Peripheral Disruption of the Grb10 Gene Enhances Insulin Signaling and Sensitivity In Vivo
- Pioglitazone in the treatment of NASH: the role of adiponectin
- The Fate of Taspoglutide, a Weekly GLP-1 Receptor Agonist, Versus Twice-Daily Exenatide for Type 2 Diabetes
- Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance
- Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis
- Real-World Treatment Patterns of Sacubitril/Valsartan: A Longitudinal Cohort Study in Germany
- Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo
- Whole body overexpression of PGC-1α has opposite effects on hepatic and muscle insulin sensitivity
- Primary results from the phase III ALUR study of alectinib versus chemotherapy in previously treated ALK+ non-small-cell lung cancer (NSCLC)
- 40th EASD Annual Meeting of the European Association for the Study of Diabetes
- Early insights into the characteristics and evolution of clinical parameters in a cohort of patients prescribed sacubitril/valsartan in Germany
- Decreased Non–Insulin-Dependent Glucose Clearance Contributes to the Rise in Fasting Plasma Glucose in the Nondiabetic Range
- DT‐01‐03: Efficacy and safety of gantenerumab in prodromal Alzheimer's disease: Results from scarlet road—a global, multicenter trial
- Genetic Disruption of SOD1 Gene Causes Glucose Intolerance and Impairs β-Cell Function